Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep

Haney, Margaret, Gunderson, Erik W, Rabkin, Judith, Hart, Carl L, Vosburg, Suzanne K, Comer, Sandra D, Foltin, Richard W · 2007 · JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

OBJECTIVES: Individuals with HIV constitute the largest group using cannabinoids for medicinal reasons; yet, no studies have directly compared the tolerability and efficacy of smoked marijuana and oral dronabinol maintenance in HIV-positive marijuana smokers. This placebo-controlled within-subjects study evaluated marijuana and dronabinol across a range of behaviors: eating topography, mood, cognitive performance, physiologic measures, and sleep. METHODS: HIV-positive marijuana smokers (n = 10) completed 2 16-day inpatient phases. Each dronabinol (5 and 10 mg) and marijuana (2.0% and 3.9% Delta9-tetrahydrocannabinol [THC]) dose was administered 4 times daily for 4 days, but only 1 drug was active per day, thereby maintaining double-blind dosing. Four days of placebo washout separated each active cannabinoid condition. RESULTS: As compared with placebo, marijuana and dronabinol dose dependently increased daily caloric intake and body weight in HIV-positive marijuana smokers. All cannabinoid conditions produced significant intoxication, except for low-dose dronabinol (5 mg); the intoxication was rated positively (eg, "good drug effect") with little evidence of discomfort and no impairment of cognitive performance. Effects of marijuana and dronabinol were comparable, except that only marijuana (3.9% THC) improved ratings of sleep. CONCLUSIONS: These data suggest that for HIV-positive marijuana smokers, both dronabinol (at doses 8 times current recommendations) and marijuana were well tolerated and produced substantial and comparable increases in food intake.

Overview

Integrity signals

Registry

Crossref · 10.1097/qai.0b013e31811ed205

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 56 references

Cited by

See all 187

Metadata

Authors
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W.
Affiliations
New York State Psychiatric Institute (US)
Corresponding author
  • Haney, Margaret
  • Gunderson, Erik W
  • Rabkin, Judith
  • Hart, Carl L
  • Vosburg, Suzanne K
  • Comer, Sandra D
  • Foltin, Richard W
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2007-08-15
Volume
45
Issue
5
Pages
545-554
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2148291582
Cited by
184
References
56
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 20 · 2021: 10 · 2020: 13 · 2019: 11 · 2018: 17 · 2017: 16 · 2016: 11 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 3
FWCI
3.34
Type
journal article
Language
en
Open access
closed
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Drug Abuse (DA-09236, R01DA012698, P50DA009236, DA12698)
  • National Center for Complementary and Alternative Medicine
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords
dronabinol, cannabis smoking, cannabinoids, delta-9-tetrahydrocannabinol, dietary intake, weight gain, poisoning, sleep, cognitive performance, tolerability
MeSH terms
Administration, Oral, Adult, Cannabis, Double-Blind Method, Eating, Female, HIV, Humans, Male, Marijuana Smoking, Psychotropic Drugs, Dronabinol, HIV Infections, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep. https://app.cochat.ai/papers/10.1097/qai.0b013e31811ed205
The paper
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007). Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0b013e31811ed205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.